Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$27.26
+1.52%
Mkt Cap $401.38M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (17 analysts)
$72.00
Range $65.00 – $81.00
Implied Upside
+164.2%
Consensus $72.00 vs current $27.26
NASDAQ·Healthcare·Biotechnology
$27.26
+1.52%
Mkt Cap $401.38M
Buy
4
Hold
0
Sell
0
Price Target (17 analysts)
$72.00
Range $65.00 – $81.00
+164.2%
Consensus $72.00 vs current $27.26